Progress in PD-1-based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers

Gastroenterology. 2017 Oct;153(4):1162-1163. doi: 10.1053/j.gastro.2017.08.050. Epub 2017 Sep 1.
No abstract available

Publication types

  • Comment

MeSH terms

  • CD28 Antigens
  • CD8-Positive T-Lymphocytes
  • Colon
  • Gastrointestinal Neoplasms*
  • Humans
  • Immunotherapy
  • Programmed Cell Death 1 Receptor*
  • T-Lymphocytes

Substances

  • CD28 Antigens
  • Programmed Cell Death 1 Receptor